Fig. 1From: Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeuticsmiRNA and siRNA structures. A miRNAs are characterized by a 7 nucleotide “seed sequence” that determines gene silencing by binding the 3′ UTR of mRNA target. B siRNAs bind fully complementary sequences on the mRNA target that is than degradedBack to article page